相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of Neutral Sphingomyelinase Contributes to Nitric Oxide-Mediated Flow-Induced Dilation in the Human Microvasculature
Mary Schulz et al.
FASEB JOURNAL (2020)
Redox Signaling and Regional Heterogeneity of Endothelial Dysfunction indb/dbMice
Nada A. Sallam et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases
Mohamad Adada et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2016)
Cellular function and signaling pathways of vascular smooth muscle cells modulated by sphingosine 1-phosphate
Takuji Machida et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Diacylglycerol Kinase-epsilon: Properties and Biological Roles
Richard M. Epand et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
Richard L. Proia et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission
Tulika Arora et al.
PLOS ONE (2015)
Involvement of neutral sphingomyelinase in the angiotensin II signaling pathway
Rocio Bautista-Perez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Sphingolipids as modulators of membrane proteins
Andreas Max Ernst et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
The secretory deficit in islets from db/db mice is mainly due to a loss of responding beta cells
Oanh H. Do et al.
DIABETOLOGIA (2014)
Dietary fish oil improves endothelial function and lowers blood pressure via suppression of sphingolipid-mediated contractions in spontaneously hypertensive rats
Lieke W. J. van den Elsen et al.
JOURNAL OF HYPERTENSION (2014)
Review: Novel insights into the regulation of vascular tone by sphingosine 1-phosphate
D. Kerage et al.
PLACENTA (2014)
Endothelium in Spots - High-Content Imaging of Lipid Rafts Clusters in db/db Mice
Marta Pilarczyk et al.
PLOS ONE (2014)
Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Bingxuan Wang et al.
CURRENT DIABETES REVIEWS (2014)
Lipotoxicity contributes to endothelial dysfunction: A focus on the contribution from ceramide
J. David Symons et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2013)
Sphingolipid Signaling in Metabolic Disorders
Timothy Hla et al.
CELL METABOLISM (2012)
Ceramide kinase deficiency improves diet-induced obesity and insulin resistance
Susumu Mitsutake et al.
FEBS LETTERS (2012)
Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 Diabetes
Susumu Mitsutake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Circulating sphingolipid biomarkers in models of type 1 diabetes
Todd E. Fox et al.
JOURNAL OF LIPID RESEARCH (2011)
Hypertension Is Associated with Marked Alterations in Sphingolipid Biology: A Potential Role for Ceramide
Leon J. A. Spijkers et al.
PLOS ONE (2011)
Antihypertensive Treatment Differentially Affects Vascular Sphingolipid Biology in Spontaneously Hypertensive Rats
Leon J. A. Spijkers et al.
PLOS ONE (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
An update on sphingosine-1-phosphate and other sphingolipid mediators
Henrik Fyrst et al.
NATURE CHEMICAL BIOLOGY (2010)
Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction
Angel Cogolludo et al.
CARDIOVASCULAR RESEARCH (2009)
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology
Catherine Pavoine et al.
CARDIOVASCULAR RESEARCH (2009)
Sphingosine-1-phosphate and modulation of vascular tone
Junsuke Igarashi et al.
CARDIOVASCULAR RESEARCH (2009)
Sphingolipids: players in the pathology of metabolic disease
L. Ashley Cowart
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Sphingolipids, insulin resistance, and metabolic disease:: New insights from in vivo manipulation of sphingolipid metabolism
William L. Holland et al.
ENDOCRINE REVIEWS (2008)
Anionic lipids activate group IVA cytosolic phospholipase A2 via distinct and separate mechanisms
Preeti Subramanian et al.
JOURNAL OF LIPID RESEARCH (2007)
Contribution of sphingolipids to the pathogenesis of obesity
Fahumiya Samad
FUTURE LIPIDOLOGY (2007)
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
Dagmar Meyer zu Heringdorf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Sphingosine-1-phosphate signaling in the cardiovascular system
Stephan L. M. Peters et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice
Tze Yan Lam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Altered adipose and plasma sphingolipid metabolism in obesity - A potential mechanism for cardiovascular and metabolic risk
Fahumiya Samad et al.
DIABETES (2006)
Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine
MR Hojjati et al.
JOURNAL OF LIPID RESEARCH (2006)
Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors - A novel pathway relevant to the pathophysiology of endothelium
C De Palma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
C2-ceramide induces vasodilation in phenylephrine-induced pre-contracted rat thoracic aorta:: role of RhoA/Rho-kinase and intracellular Ca2+ supercript stop concentration
GJ Jang et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
Endothelial NOS-mediated relaxations of isolated thoracic aorta of the C57BL/6J mouse a methodological study
B Horváth et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Sphingomyelinase causes endothelium-dependent vasorelaxation through endothelial nitric oxide production without cytosolic Ca2+ elevation
K Mogami et al.
FEBS LETTERS (2005)
Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release
BJ Pettus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Caveolin, caveolae, and endothelial cell function
PG Frank et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice
E Aasum et al.
DIABETES (2003)
Lipoapoptosis: its mechanism and its diseases
RH Unger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind.
YA Hannun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke
BM Altura et al.
BRAIN RESEARCH BULLETIN (2002)
Pathogenesis of type 2 diabetes - Insulin resistance
G Boden
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2001)
Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells
E Romiti et al.
FEBS LETTERS (2001)
Sphingolipid transport in eukaryotic cells
G van Meer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Sphingomyelinase and ceramide analogs induce contraction and rises in [Ca2+]i in canine cerebral vascular muscle
T Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca2+ mobilization in rat aortic smooth muscle
T Zheng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Ceramide in the eukaryotic stress response
YA Hannun et al.
TRENDS IN CELL BIOLOGY (2000)
分享论文
